- Home
- SLNO vs GVA Comparison
SLNO vs GVA Comparison
Compare SLNO & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- GVA
- Stock Information
- Founded
- SLNO 1999
- GVA 1922
- Country
- SLNO United States
- GVA United States
- Employees
- SLNO N/A
- GVA N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GVA Military/Government/Technical
- Sector
- SLNO Health Care
- GVA Industrials
- Exchange
- SLNO Nasdaq
- GVA Nasdaq
- Market Cap
- SLNO 3.2B
- GVA 3.8B
- IPO Year
- SLNO 2014
- GVA 1990
- Fundamental
- Price
- SLNO $74.47
- GVA $88.69
- Analyst Decision
- SLNO Strong Buy
- GVA Strong Sell
- Analyst Count
- SLNO 9
- GVA 1
- Target Price
- SLNO $103.33
- GVA $76.00
- AVG Volume (30 Days)
- SLNO 744.8K
- GVA 601.5K
- Earning Date
- SLNO 05-07-2025
- GVA 05-01-2025
- Dividend Yield
- SLNO N/A
- GVA 0.58%
- EPS Growth
- SLNO N/A
- GVA 218.05
- EPS
- SLNO N/A
- GVA 2.58
- Revenue
- SLNO N/A
- GVA $4,034,846,000.00
- Revenue This Year
- SLNO N/A
- GVA $7.95
- Revenue Next Year
- SLNO N/A
- GVA $6.03
- P/E Ratio
- SLNO N/A
- GVA $34.67
- Revenue Growth
- SLNO N/A
- GVA 11.42
- 52 Week Low
- SLNO $36.93
- GVA $58.23
- 52 Week High
- SLNO $80.99
- GVA $105.20
- Technical
- Relative Strength Index (RSI)
- SLNO 50.25
- GVA 60.50
- Support Level
- SLNO $72.59
- GVA $84.45
- Resistance Level
- SLNO $78.32
- GVA $91.99
- Average True Range (ATR)
- SLNO 2.70
- GVA 1.80
- MACD
- SLNO -0.63
- GVA 0.04
- Stochastic Oscillator
- SLNO 32.52
- GVA 47.75
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About GVA Granite Construction Incorporated
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.